Close Menu

NEW YORK (GenomeWeb) – MolecularMD announced today that it will now provide Promega's Microsatellite Instability (MSI) v1.2 Analysis System as part of a larger portfolio of diagnostic and clinical research products aimed at supporting the development of oncology drugs and clinical trials.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.